Logo image
Quality control systems in cardiac aging
Journal article   Open access   Peer reviewed

Quality control systems in cardiac aging

Ellen K Quarles, Dao-Fu Dai, Autumn Tocchi, Nathan Basisty, Lemuel Gitari and Peter S Rabinovitch
Ageing research reviews, Vol.23(Pt A), pp.101-115
09/2015
DOI: 10.1016/j.arr.2015.02.003
PMCID: PMC4686341
PMID: 25702865
url
https://www.ncbi.nlm.nih.gov/pmc/articles/4686341View
Open Access

Abstract

Cardiac aging is an intrinsic process that results in impaired cardiac function, along with cellular and molecular changes. These degenerative changes are intimately associated with quality control mechanisms. This review provides a general overview of the clinical and cellular changes which manifest in cardiac aging, and the quality control mechanisms involved in maintaining homeostasis and retarding aging. These mechanisms include autophagy, ubiquitin-mediated turnover, apoptosis, mitochondrial quality control and cardiac matrix homeostasis. Finally, we discuss aging interventions that have been observed to impact cardiac health outcomes. These include caloric restriction, rapamycin, resveratrol, GDF11, mitochondrial antioxidants and cardiolipin-targeted therapeutics. A greater understanding of the quality control mechanisms that promote cardiac homeostasis will help to understand the benefits of these interventions, and hopefully lead to further improved therapeutic modalities.
DNA Repair Animals Aging - physiology Diet Heart - growth & development Heart - physiology Humans Aging - drug effects Heart - drug effects Quality Control

Details

Metrics

Logo image